Plant Comparison

Bistort vs Purple coneflower

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant ABistortBistorta officinalisPolygonaceaeFull monograph →
Plant BPurple coneflowerEchinacea purpureaAsteraceaeFull monograph →

At a glance

Bistort and Purple coneflower: they share 5 indicated uses (arthritis / joint pain, infection (general), inflammation (general), …); 2 pharmacological actions in common.

BistortPurple coneflower
Constituents33
Pharmacological actions73
Indicated uses107
Safety notes32
Cited sources1419
Indicated uses
Only Bistort
BruisingCancer (anticancer research)DiarrhoeaHeavy menstrual bleedingSore throat
Shared (5)
Arthritis / joint painInfection (general)Inflammation (general)Skin irritationWounds
Only Purple coneflower
Cold & fluImmune support
Pharmacological actions
Only Bistort
Anticancer (preclinical)AntidiarrhoealAstringentStyptic / haemostaticVulnerary (wound healing)
Shared (2)
Anti-inflammatoryAntimicrobial
Only Purple coneflower
Immunomodulator / immune support

Evidence face-off — shared uses

ConditionBistortPurple coneflowerVerdict
Arthritis / joint pain1/101/10Comparable evidence
Infection (general)1/101/10Comparable evidence
Inflammation (general)1/101/10Comparable evidence
Skin irritation1/101/10Comparable evidence
Wounds1/101/10Comparable evidence

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Tannins (15-36% of the rhizome: oligomeric proanthocyanidins, gallotannins, catechins)[13, 14]

Very high tannin content is the basis of the strong astringency.

ProanthocyanidinsTanninsCatechins
Phenolic acids and flavonoids[14]

Contribute to antioxidant and antibacterial activity.

Phenolic acidsFlavonoids
Starch and oxalic acid[13]

Other rhizome constituents.

Starch
Alkamides[4]

Lipophilic alkamides are considered key immunomodulatory and anti-inflammatory constituents, particularly concentrated in the root.

Caffeic acid derivatives (echinacoside, cichoric acid)[4]

Antioxidant phenolic compounds contributing to the plant's immunomodulatory activity.

Caffeic acidPhenolic acids
Polysaccharides[4]

Water-soluble polysaccharides associated with immune-stimulating activity, particularly from the aerial parts.

Polysaccharides

Pharmacological Actions

Anti-inflammatory[4, 13, 14]

Anti-inflammatory gargle / mouthwash for inflammation of the mouth and throat (sore throat)

Anticancer (preclinical)[10, 11]

Bistorta officinalis (Polygonum bistorta) rhizome extract, rich in gallotannins and phenolic acids, shows cytotoxic and pro-apoptotic activity against hepatocellular and other cancer cells (preclinical).

Antidiarrhoeal[4, 13, 14]

Astringent for mild diarrhoea (tannins tighten the gut lining and reduce excess secretion)

Antimicrobial[2, 12, 14]

Antibacterial (topical) - GC-MS-characterised extracts showed antibacterial activity

Astringent[7, 13, 14]

Astringent for mild diarrhoea (tannins tighten the gut lining and reduce excess secretion)

Styptic / haemostatic[13, 14]

Vulnerary and styptic for minor wounds (topical)

Vulnerary (wound healing)[13, 14]

Vulnerary and styptic for minor wounds (topical)

Anti-inflammatory[4, 11, 15, 16, 17]
Antimicrobial[7, 8, 10, 15, 16, 17]
Immunomodulator / immune support[4, 5, 6, 8, 9, 15, 16, 17]

Traditional & Indicated Uses

Arthritis / joint pain[13, 14]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Bruising[13, 14]Traditional · 1/10

inferred from vulnerary action

Evidence: 1
Label: Bruising
Cancer (anticancer research)[10, 11]Traditional · 2/10

Polygonum bistorta (Bistorta officinalis) methanol-water and aqueous extracts inhibit hepatocellular carcinoma cells via ROS-induced ER stress and apoptosis (delaying xenograft tumour growth), with phenolic constituents driving the cytotoxicity (preclinical).

Evidence: 2
Label: Cancer (anticancer research)
Diarrhoea[13, 14]Traditional · 1/10

Astringent for mild diarrhoea (tannins tighten the gut lining and reduce excess secretion)

Evidence: 1
Label: Diarrhoea
Heavy menstrual bleeding[13, 14]Traditional · 1/10

inferred from styptic action

Evidence: 1
Label: Heavy menstrual bleeding
Infection (general)[12, 14]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[13, 14]Traditional · 1/10

Anti-inflammatory gargle / mouthwash for inflammation of the mouth and throat (sore throat)

Evidence: 1
Label: Inflammation (general)
Skin irritation[13, 14]Traditional · 1/10

inferred from astringent action

Evidence: 1
Label: Skin irritation
Sore throat[13, 14]Traditional · 1/10

Anti-inflammatory gargle / mouthwash for inflammation of the mouth and throat (sore throat)

Evidence: 1
Label: Sore throat
Wounds[13, 14]Traditional · 1/10

Vulnerary and styptic for minor wounds (topical)

Evidence: 1
Label: Wounds
Arthritis / joint pain[15, 16, 17]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Cold & flu[15, 16, 17]Traditional · 1/10

inferred from immunomodulator action

Evidence: 1
Label: Cold & flu
Immune support[15, 16, 17]Traditional · 1/10
Evidence: 1
Label: Immune support
Infection (general)[15, 16, 17]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[15, 16, 17]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Skin irritation[15, 16, 17]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Wounds[15, 16, 17]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds

Safety, Cautions & Contraindications

Safety note[13]Info

Very tannin-rich: high or prolonged intake may cause stomach upset or constipation and can reduce the absorption of iron and some medicines taken at the same time.

Safety note[13]Info

Traditional use only; diarrhoea persisting beyond a few days, or mouth/throat inflammation that does not settle, needs medical assessment.

Safety note[13]Caution

Safety in pregnancy and breastfeeding is not established; avoid medicinal doses.

Safety note[15, 16, 17]Caution

Generally considered safe, but caution advised for those with autoimmune conditions. Not recommended for long-term use (more than 8 weeks continuously).

Safety note[15, 16, 17, 18]Caution

Duke (2002) rates echinacea as +++ — among the most thoroughly documented herbal immunostimulants. It notes experimental and clinical evidence for immunostimulant, antiviral, and anti-inflammatory activities. Multiple species have been studied (E. purpurea, E. angustifolia, E. pallida), and Duke emphasizes that species identification in commercial products is often unreliable. Commission E approves E. purpurea for supporting immune function during colds and flu. Dose: 900 mg standardized extract daily in acute use; use should be limited to 8 weeks continuous. Contraindicated in autoimmune diseases (MS, lupus, HIV/AIDS), tuberculosis, and with immunosuppressive drugs (cyclosporine) (Duke, 2002).

External Ids

Gbif: 7925535
Wikidata: Q112917
Gbif: 3150935
Powo: urn:lsid:ipni.org:names:1174497-2
Wikidata: Q272661

Botanical Description

Perennial herb rising from a thick, twisted, S- or snake-shaped rhizome (giving the names 'bistort' and 'snakeroot'), blackish outside and pink inside. The basal leaves are broadly oval to lance-shaped on long stalks; stem leaves are smaller and stalkless. A single dense, cylindrical spike of small, pale pink flowers is borne atop each unbranched flowering stem.[14]

Height: 30-80 cm
Habit: Erect perennial herb from a twisted rhizome
Leaves: Basal leaves broadly oval to lance-shaped, long-stalked; stem leaves smaller, stalkless
Flowers: Dense, cylindrical spike of small pale pink flowers atop an unbranched stem
Stem: Erect, unbranched, one flower spike per stem
Root: Thick, twisted, S-shaped (snake-like) rhizome, blackish outside, pink inside
Fruit: Small, glossy, three-angled achene
Flowering Period: May-August

Robust perennial herb with a basal rosette of coarse, hairy, lance-shaped leaves and tall, sturdy flowering stems. Each stem bears a single large, daisy-like flower head with drooping (reflexed), rose-purple to pink ray florets surrounding a prominent, spiny, orange-brown central cone of disc florets.[4]

Height: 60-150 cm
Habit: Robust, clump-forming perennial herb
Leaves: Coarse, hairy, lance-shaped, in a basal rosette
Flowers: Large daisy-like heads with drooping rose-purple ray florets around a spiny orange-brown cone
Stem: Tall, sturdy, hairy, mostly unbranched
Root: Thick, fibrous, black-brown taproot
Fruit: Small four-angled achene
Flowering Period: June-September

Habitat

Grows in damp meadows, pastures, streamsides and mountain grassland on moist, often calcareous soils; native to Europe and temperate Asia, favouring cooler upland regions.[14]

Native to the tallgrass prairies, open woodland and dry meadows of central and eastern North America; widely cultivated worldwide as a garden and medicinal plant.[4]

Harvesting

The rhizome is dug in autumn or early spring, when tannin content is highest, cleaned and dried; aerial parts are gathered in summer while flowering.[14]

Parts: Rhizome (root) and aerial parts
Season: Rhizome in autumn or early spring; aerial parts in summer flowering

The flower heads are picked as they open, in summer; the root is dug in autumn from plants at least two to three years old, when its content of bioactive alkamides and caffeic acid derivatives is highest, then cleaned and dried.[4]

Parts: Flower, Root
Season: Flower in summer; root in autumn from mature plants

Traditional Uses

Bistort rhizome, one of the most tannin-rich temperate herbs, has a long European folk history as a powerful astringent for mild diarrhoea, as a gargle for sore throat and mouth inflammation, and topically as a vulnerary and styptic for minor wounds and bleeding; young leaves have also traditionally been eaten as a spring pot-herb ('Easter-ledge pudding').[13, 14]

Echinacea root was widely used by Native American peoples as a remedy for infections, wounds, snakebite and toothache, and entered nineteenth-century Eclectic medicine as a broad anti-infective. It remains best known today, in standardised aerial-part or root extracts, as a supportive remedy for preventing and shortening the common cold and supporting immune function.[1, 4]

Preparations

Decoction (rhizome)[14]

Dried rhizome simmered in water as a strongly astringent traditional remedy for diarrhoea, or used as a gargle/mouthwash for sore throat.

Poultice/wash[13]

Crushed rhizome or aerial parts applied externally, or used as a wash, for minor wounds and bleeding.

Standardised extract[1]

Fresh-pressed juice or standardised extract of the aerial parts or root, taken as tablets, drops or capsules at the first sign of a cold; the best-studied clinical form.

References

REF-0746, REF-0747, REF-0748, REF-2116, REF-2117, REF-2118, REF-2119, REF-2120, REF-2121, REF-2122, REF-2123, REF-0627
REF-0797, REF-0798, REF-0799, REF-2011, REF-2012, REF-2013, REF-2014, REF-2015, REF-2016, REF-2017, REF-2018, REF-2019, REF-2020, REF-2021

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

Dosage

Not documented

Standardised extract[1]

Clinical trials for the common cold commonly use around 300-900 mg of standardised extract daily, started at the first sign of symptoms and continued for up to 7-10 days; continuous use beyond about 8 weeks is not recommended. Educational reference only, not a prescription.

Drug Class Interactions

Not documented

Safety note[19]Caution
Drug Class: immunosuppressants
Mechanism: Echinacea can both stimulate immune activity and alter CYP3A/CYP1A2 enzymes, so it may reduce the effect or change the blood levels of immunosuppressant drugs such as ciclosporin and tacrolimus; use only under medical supervision after a transplant or with autoimmune therapy.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

References & Sources

  1. Pawłowska, K.A., Hałasa, R., Dudek, M.K., Majdan, M. et al (2020) 'Antibacterial and anti-inflammatory activity of bistort (Bistorta officinalis) aqueous extract and its major components: justification of the usage of the medicinal plant material as a traditional topical agent', Journal of Ethnopharmacology, 260, pp. 113077. doi:10.1016/j.jep.2020.113077 Preclinical
    https://doi.org/10.1016/j.jep.2020.113077
  2. Jovanović, M., Morić, I., Nikolić, B., Pavić, A. et al (2020) 'Anti-Virulence Potential and In Vivo Toxicity of Persicaria maculosa and Bistorta officinalis Extracts', Molecules, 25(8), pp. 1811. doi:10.3390/molecules25081811 Preclinical
    https://doi.org/10.3390/molecules25081811
  3. Duwiejua, M., Zeitlin, I.J., Waterman, P.G. and Gray, A.I (1994) 'Anti-inflammatory activity of Polygonum bistorta, Guaiacum officinale and Hamamelis virginiana in rats', Journal of Pharmacy and Pharmacology, 46(4), pp. 286-290. doi:10.1111/j.2042-7158.1994.tb03795.x Preclinical
    https://doi.org/10.1111/j.2042-7158.1994.tb03795.x
  4. Esmaealzadeh, N., Abdolghaffari, A., Baeeri, M., Hasanpour, M., Iranshahi, M., Santarcangelo, C., Gholami, M. and Bahramsoltani, R (2024) 'Protective effect of freeze-dried extract of Persicaria bistorta Samp. on acetic acid-induced colitis model in rats: involvement of nitric oxide and opioid system', Inflammopharmacology, 32(6), pp. 3845-3861. doi:10.1007/s10787-024-01518-8 Preclinical
    https://doi.org/10.1007/s10787-024-01518-8
  5. Klimczak, U., Wozniak, M., Tomczyk, M. and Granica, S (2017) 'Chemical composition of edible aerial parts of meadow bistort (Persicaria bistorta (L.) Samp.)', Food Chemistry, 230, pp. 281-290. doi:10.1016/j.foodchem.2017.02.128 Preclinical
    https://doi.org/10.1016/j.foodchem.2017.02.128
  6. Manoharan, K.P., Benny, T.K.H. and Yang, D (2005) 'Cycloartane type triterpenoids from the rhizomes of Polygonum bistorta', Phytochemistry, 66(19), pp. 2304-2308. doi:10.1016/j.phytochem.2005.07.008 Preclinical
    https://doi.org/10.1016/j.phytochem.2005.07.008
  7. Liu, X., Hua, H., Liu, J., Chen, F. and Wu, L (2006) 'A new tannin-related compound from the rhizome of Polygonum bistorta L', Journal of Asian Natural Products Research, 8(4), pp. 299-302. doi:10.1080/10286020500034956 Preclinical
    https://doi.org/10.1080/10286020500034956
  8. Yang, W., Qian, Z., Wu, M., Gao, J., Huang, Q., Zou, Y. and Tang, D (2023) 'Online microextraction coupled with HPLC-ABTS for rapid analysis of antioxidants from the root of Polygonum bistorta', Evidence-Based Complementary and Alternative Medicine, 2023, pp. 7496848. doi:10.1155/2023/7496848 Preclinical
    https://doi.org/10.1155/2023/7496848
  9. Bauer, I., Rimbach, G., Nevermann, S., Neuhauser, C., Schwarzinger, B., Schwarzinger, C., Weghuber, J. and Luersen, K (2023) 'In-vitro antidiabetic activity of a Bistorta officinalis Delarbre root extract can not be confirmed in the in-vivo models hen's egg test and Drosophila melanogaster', Journal of Physiology and Pharmacology, 74(1). doi:10.26402/jpp.2023.1.04 Preclinical
    https://doi.org/10.26402/jpp.2023.1.04
  10. Intisar, A., Zhang, L., Luo, H., Kiazolu, J.B., Zhang, R. and Zhang, W (2012) 'Anticancer constituents and cytotoxic activity of methanol-water extract of Polygonum bistorta L', African Journal of Traditional, Complementary and Alternative Medicines, 10(1), pp. 53-59. doi:10.4314/ajtcam.v10i1.9 Preclinical
    https://doi.org/10.4314/ajtcam.v10i1.9
  11. Liu, Y., Weng, Y., Lin, H., Tang, S., Chen, C., Liang, C., Ku, C. and Lin, J (2017) 'Aqueous extract of Polygonum bistorta modulates proteostasis by ROS-induced ER stress in human hepatoma cells', Scientific Reports, 7, pp. 41437. doi:10.1038/srep41437 Preclinical
    https://doi.org/10.1038/srep41437
  12. Khan, S., Arshad, S., Masood, I., Arif, A., Abbas, S., Qureshi, A.W., Parveen, A. and Seemab Ameen, Z (2023) 'GC-MS Analysis of Persicaria bistorta: Uncovering the Molecular Basis of Its Traditional Medicinal Use', Applied Biochemistry and Biotechnology, 196(4), pp. 2270--2288. doi:10.1007/s12010-023-04580-0 Traditional / reference
    https://doi.org/10.1007/s12010-023-04580-0
  13. WebMD (n.d.) 'Bistort: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews'. Available at: https://www.webmd.com/vitamins/ai/ingredientmono-75/bistort Traditional / reference
    https://www.webmd.com/vitamins/ai/ingredientmono-75/bistort
  14. (2020) 'Antibacterial and anti-inflammatory activity of bistort (Bistorta officinalis) aqueous extract and its major components - justification of the usage of the medicinal plant material as a traditional topical agent', Journal of Ethnopharmacology. doi:10.1016/j.jep.2020.113077 Traditional / reference
    https://doi.org/10.1016/j.jep.2020.113077
  1. Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R. et al (2014) 'Echinacea for preventing and treating the common cold', Cochrane Database of Systematic Reviews, 2(2), pp. CD000530. doi:10.1002/14651858.CD000530.pub3 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD000530.pub3
  2. Kamin, W., Seifert, G., Zwiauer, K., Bonhoeffer, J. et al (2025) 'Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review', Frontiers in Pediatrics, 13, pp. 1423250. doi:10.3389/fped.2025.1423250 Meta-analysis / review
    https://doi.org/10.3389/fped.2025.1423250
  3. Fashner, J., Ericson, K. and Werner, S (2012) 'Treatment of the common cold in children and adults', American Family Physician, 86(2), pp. 153-159. Available at: https://pubmed.ncbi.nlm.nih.gov/22962927/ Traditional / reference
    https://pubmed.ncbi.nlm.nih.gov/22962927/
  4. Manayi, A., Vazirian, M. and Saeidnia, S (2015) 'Echinacea purpurea: Pharmacology, phytochemistry and analysis methods', Pharmacognosy Reviews, 9(17), pp. 63-72. doi:10.4103/0973-7847.156353 Meta-analysis / review
    https://doi.org/10.4103/0973-7847.156353
  5. Burlou-Nagy, C., Banica, F., Jurca, T., Vicas, L.G., Marian, E., Muresan, M.E., Bacskay, I., Kiss, R., Feher, P. and Pallag, A (2022) 'Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review', Plants, 11(9), pp. 1244. doi:10.3390/plants11091244 Meta-analysis / review
    https://doi.org/10.3390/plants11091244
  6. Hall, H., Fahlman, M.M. and Engels, H.J (2007) 'Echinacea purpurea and mucosal immunity', International Journal of Sports Medicine, 28(9), pp. 792-797. doi:10.1055/s-2007-964895 Randomized trial
    https://doi.org/10.1055/s-2007-964895
  7. Ross, S.M (2016) 'Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold', Holistic Nursing Practice, 30(1), pp. 54-57. doi:10.1097/HNP.0000000000000130 Meta-analysis / review
    https://doi.org/10.1097/HNP.0000000000000130
  8. Hudson, J.B (2011) 'Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases', Journal of Biomedicine & Biotechnology, 2012, pp. 769896. doi:10.1155/2012/769896 Meta-analysis / review
    https://doi.org/10.1155/2012/769896
  9. Mishima, S., Saito, K., Maruyama, H., Inoue, M., Yamashita, T., Ishida, T. and Gu, Y (2004) 'Antioxidant and immuno-enhancing effects of Echinacea purpurea', Biological & Pharmaceutical Bulletin, 27(7), pp. 1004-1009. doi:10.1248/bpb.27.1004 Preclinical
    https://doi.org/10.1248/bpb.27.1004
  10. Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103 Clinical study
    https://doi.org/10.1139/Y07-103
  11. Micheli, L., Maggini, V., Ciampi, C., Gallo, E., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Di Cesare Mannelli, L., De Leo, M. and Firenzuoli, F (2022) 'Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy', Phytotherapy Research, 37(5), pp. 1911-1923. doi:10.1002/ptr.7709 Preclinical
    https://doi.org/10.1002/ptr.7709
  12. Gholami, M., Amri, J., Pazhoohan, S. and Sadegh, M (2021) 'Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor', Journal of Complementary & Integrative Medicine, 19(4), pp. 879-886. doi:10.1515/jcim-2020-0219 Preclinical
    https://doi.org/10.1515/jcim-2020-0219
  13. Awortwe, C., Bruckmueller, H., Kaehler, M. and Cascorbi, I (2021) 'Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters', Molecular Pharmaceutics, 18(4), pp. 1622-1633. doi:10.1021/acs.molpharmaceut.0c01075 Preclinical
    https://doi.org/10.1021/acs.molpharmaceut.0c01075
  14. Perry, N.B., van Klink, J.W., Burgess, E.J. and Parmenter, G.A (1997) 'Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers', Planta Medica, 63(1), pp. 58-62. doi:10.1055/s-2006-957605 Preclinical
    https://doi.org/10.1055/s-2006-957605
  15. Linde, K., Barrett, B., Wölkart, K., Bauer, R. and Melchart, D (2006) 'Echinacea for preventing and treating the common cold'. Traditional / reference
    https://scholar.google.com/scholar?q=Echinacea%20for%20preventing%20and%20treating%20the%20common%20cold
  16. Sharma, M., Schoop, R., Suter, A. and Schoop, W (2010) 'The possibility of prophylactic treatment of streptococcal pharyngotonsillitis with a standardized Echinacea preparation', 29(8), pp. 1025--1035. Traditional / reference
    https://scholar.google.com/scholar?q=The%20possibility%20of%20prophylactic%20treatment%20of%20streptococcal%20pharyngotonsillitis%20with%20a%20standardized%20Echinacea%20preparation
  17. World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
    https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants
  18. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  19. Gorski, J.C., Huang, S.M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., Miller, M. and Hall, S.D (2004) 'The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo', Clinical Pharmacology and Therapeutics, 75(1), pp. 89-100. doi:10.1016/j.clpt.2003.09.013 Clinical study
    https://doi.org/10.1016/j.clpt.2003.09.013

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.